Outcomes of First-Line Chemotherapy in Patients with Advanced or Metastatic Leiomyosarcoma of Uterine and Non-Uterine Origin

Table 3

Response rate of first line chemotherapy.

Best response	Non-Uterine	%	Uterine	%
(WHO/RECIST)	(𝑛=32)		(𝑛=33)
CR	0		1	3
PR	7	22	4	12
SD	15	47	14	42
PD	9	28	14	42
Non-evaluable	1	3	0	0

CR: complete response, PR: partial response, SD: stable disease, PD: progressive disease.